{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:39:36Z","timestamp":1787506776307,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bone.2015.04.042","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:57:28Z","timestamp":1430614648000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study"],"prefix":"10.1016","volume":"78","author":[{"given":"Alexis J.","family":"Feuer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Demmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Vogiatzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2015.04.042_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201006123","article-title":"The two faces of serotonin in bone biology","volume":"191","author":"Ducy","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2015.04.042_bb0010","series-title":"Translational endocrinology of bone, reproduction, metabolism, and the central nervous system","article-title":"Clinical implications of serotonin regulation of bone mass","author":"Haney","year":"2012"},{"key":"10.1016\/j.bone.2015.04.042_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-med-090710-133426","article-title":"Regulation of bone mass by serotonin: molecular biology and therapeutic implications","volume":"62","author":"Karsenty","year":"2011","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.bone.2015.04.042_bb0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2015.04.042_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-012-2015-9","article-title":"Relationship between use of antidepressants and risk of fractures: a meta-analysis","volume":"24","author":"Rabenda","year":"2013","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.bone.2015.04.042_bb0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1532-5415.2007.01194.x","article-title":"Depressive symptoms and rates of bone loss at the hip in older women","volume":"55","author":"Diem","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.bone.2015.04.042_bb0035","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","article-title":"Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men","volume":"167","author":"Haney","year":"2007","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards","year":"2007","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","article-title":"Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression","volume":"23","author":"Williams","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.bone.2015.04.042_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eurpsy.2010.10.006","article-title":"The adverse skeletal effects of selective serotonin reuptake inhibitors","volume":"27","author":"Tsapakis","year":"2012","journal-title":"Eur Psychiatry"},{"issue":"1","key":"10.1016\/j.bone.2015.04.042_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-011-1778-8","article-title":"Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case\u2013control studies","volume":"23","author":"Wu","year":"2012","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.bone.2015.04.042_bb0060","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Eom","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/en.2004-1259","article-title":"Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth","volume":"146","author":"Warden","year":"2005","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bone.2015.04.042_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.euroneuro.2009.05.001","article-title":"SSRIs, bone mineral density, and risk of fractures\u2014a review","volume":"19","author":"Schwan","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.bone.2015.04.042_bb0075","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/jbmr.2249","article-title":"Major depressive disorder and bone mass in adolescents and young adults","volume":"29","author":"Calarge","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.bone.2015.04.042_bb0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.clinthera.2013.07.423","article-title":"Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors","volume":"35","author":"Seifert","year":"2013","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.bone.2015.04.042_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/10640266.2013.779183","article-title":"Bone mineral density in adolescents with eating disorders exposed to selective serotonin reuptake inhibitors","volume":"21","author":"Couturier","year":"2013","journal-title":"Eat Disord"},{"issue":"3","key":"10.1016\/j.bone.2015.04.042_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4088\/JCP.08m04595gre","article-title":"A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys","volume":"71","author":"Calarge","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2015.04.042_bb0095","first-page":"1","article-title":"Mental health surveillance among children\u2014United States, 2005\u20132011","volume":"62","author":"Perou","year":"2013","journal-title":"MMWR Surveill. Summ."},{"issue":"9","key":"10.1016\/j.bone.2015.04.042_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1017\/S1092852900000559","article-title":"Use of SSRIs may impact bone density in adolescent and young women with anorexia nervosa","volume":"15","author":"Misra","year":"2010","journal-title":"CNS Spectr"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpeds.2005.09.028","article-title":"Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence","volume":"148","author":"Hammerness","year":"2006","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11920-007-0077-8","article-title":"Impact of depression and its treatment on the bones of growing children","volume":"9","author":"Weller","year":"2007","journal-title":"Curr Psychiatry Rep"},{"issue":"11","key":"10.1016\/j.bone.2015.04.042_bb0120","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1210\/jc.2013-1971","article-title":"Rates of bone loss among women initiating antidepressant medication use in midlife","volume":"98","author":"Diem","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.bone.2015.04.042_bb0125","doi-asserted-by":"crossref","first-page":"E1732","DOI":"10.1210\/jc.2014-2288","article-title":"Effects of escitalopram on markers of bone turnover: a randomized clinical trial","volume":"99","author":"Diem","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bone.2015.04.042_bb0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-014-2859-2","article-title":"Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study","volume":"26","author":"Ak","year":"2015","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.bone.2015.04.042_bb0135","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.bone.2015.04.042_bb0140","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3945\/jn.111.142059","article-title":"Food insecurity is associated with diet and bone mass disparities in early adolescent males but not females in the United States","volume":"141","author":"Eicher-Miller","year":"2011","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.2007-1894","article-title":"Vitamin D deficiency in children and its management: review of current knowledge and recommendations","volume":"122","author":"Misra","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.bone.2015.04.042_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 Pediatric Position Development Conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.bone.2015.04.042_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MOP.0b013e32831ec338","article-title":"Measurement of bone density in the pediatric population","volume":"21","author":"Bogunovic","year":"2009","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"10.1016\/j.bone.2015.04.042_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2013.12.040","article-title":"Longitudinal tracking of dual-energy X-ray absorptiometry bone measures over 6years in children and adolescents: persistence of low bone mass to maturity","volume":"164","author":"Wren","year":"2014","journal-title":"J Pediatr"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215001556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215001556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T09:38:48Z","timestamp":1566639528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328215001556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"alternative-id":["S8756328215001556"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2015.04.042","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2015.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}